Heterozygous mutations in the TREM2 gene impair microglial function and accelerate the onset of late-onset AD, affecting the wound-healing markers in astrocytes and the myelination in oligodendrocytes, with vascular abnormalities seen in pericytes. This evidence concerns the gene TREM2 and Alzheimer disease.